Transfusion premedication to prevent acute transfusion reactions: a retrospective observational study to assess current practices

BACKGROUND: The use of premedication to prevent acute transfusion reactions has been estimated to occur in 50% to 80% of transfusions. While this practice has some biologic rationale, few clinical studies have been performed to assess the efficacy of this practice, and the methodologic quality of these studies is variable. The primary objective of this study was to describe current practices regarding transfusion premedication to prevent febrile nonhemolytic transfusion reactions, mild allergic transfusion reactions, and transfusion‐associated circulatory overload.

[1]  H. Moraes-Souza.  The role of hemovigilance as a mechanism to increase transfusion safety , 2011, Revista brasileira de hematologia e hemoterapia.

[2]  G. Pomper,et al.  A prospective, randomized, double‐blind controlled trial of acetaminophen and diphenhydramine pretransfusion medication versus placebo for the prevention of transfusion reactions , 2008, Transfusion.

[3]  A. Tobian,et al.  Transfusion premedications: a growing practice not based on evidence , 2007, Transfusion.

[4]  S. Howard,et al.  Acetaminophen and diphenhydramine premedication for allergic and febrile nonhemolytic transfusion reactions: good prophylaxis or bad practice? , 2007, Transfusion medicine reviews.

[5]  C. Pui,et al.  Premedication with acetaminophen or diphenhydramine for transfusion with leucoreduced blood products in children , 2005, British journal of haematology.

[6]  J. Henry,et al.  Febrile nonhemolytic transfusion reactions. Management by premedication and cost implications in adult patients. , 2004, Archives of pathology & laboratory medicine.

[7]  M. Siegel.  To premedicate or not to premedicate. , 2004, Journal of the American Dental Association.

[8]  Edward L Snyder,et al.  Reduction of febrile but not allergic reactions to RBCs and platelets after conversion to universal prestorage leukoreduction , 2004, Transfusion.

[9]  L. Beckett,et al.  Acetaminophen and diphenhydramine as premedication for platelet transfusions: A prospective randomized double‐blind placebo‐controlled trial , 2002, American journal of hematology.

[10]  Blanchette,et al.  Effect of premedication guidelines and leukoreduction on the rate of febrile nonhaemolytic platelet transfusion reactions , 2000, Transfusion medicine.

[11]  D. Cook,et al.  Outcome assessment for clinical trials: how many adjudicators do we need? Canadian Lung Oncology Group. , 1997, Controlled clinical trials.

[12]  J. M. McCoy.  A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusions , 1994 .

[13]  L. Griffith,et al.  A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusions , 1993, Transfusion.